×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

NicoDerm CQ readies $35 mil launch

Published on .

A $30 million to $35 million campaign behind SmithKline Beecham and Hoechst Marion Roussel's nicotine patch, NicoDerm CQ, is expected to hit by mid-August from Jordan, McGrath, Case & Taylor, New York. NicoDerm, with nearly 40% of the prescription market, was cleared by FDA for over-the-counter use late last week. It follows Johnson & Johnson's Nicotrol.

Most Popular
In this article: